Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group - Rudd, R M; Gower, N H; Spiro, S G (J Clin Oncol, 2005)
, et al.